X

Xtant Medical Holdings Inc
AMEX:XTNT

Watchlist Manager
Xtant Medical Holdings Inc
AMEX:XTNT
Watchlist
Price: 0.6505 USD 1.64% Market Closed
Market Cap: 90.6m USD

Wall Street
Price Targets

XTNT Price Targets Summary
Xtant Medical Holdings Inc

Wall Street analysts forecast XTNT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XTNT is 1.785 USD with a low forecast of 1.515 USD and a high forecast of 2.1 USD.

Lowest
Price Target
1.515 USD
133% Upside
Average
Price Target
1.785 USD
174% Upside
Highest
Price Target
2.1 USD
223% Upside
Xtant Medical Holdings Inc Competitors:
Price Targets
301101
Mingyue Optical Lens Co Ltd
10% Upside
7979
Shofu Inc
46% Upside
4549
Eiken Chemical Co Ltd
13% Upside
VIMIAN
Vimian Group AB
15% Upside
300981
Zhonghong Pulin Medical Products Co Ltd
4% Downside
LNTH
Lantheus Holdings Inc
58% Upside
NAN
Nanosonics Ltd
25% Upside
BLFS
BioLife Solutions Inc
43% Upside

Revenue
Forecast

Revenue Estimate
Xtant Medical Holdings Inc

For the last 13 years the compound annual growth rate for Xtant Medical Holdings Inc's revenue is 11%. The projected CAGR for the next 2 years is 10%.

11%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Xtant Medical Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Xtant Medical Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XTNT's stock price target?
Price Target
1.785 USD

According to Wall Street analysts, the average 1-year price target for XTNT is 1.785 USD with a low forecast of 1.515 USD and a high forecast of 2.1 USD.

What is Xtant Medical Holdings Inc's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Xtant Medical Holdings Inc's revenue is 11%. The projected CAGR for the next 2 years is 10%.

Back to Top